Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Top Cited Papers
Open Access
- 15 August 2000
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (4) , 467-472
- https://doi.org/10.1172/jci10843
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- The language of covalent histone modificationsNature, 2000
- Acute troglitazone action in isolated perfused rat liverBritish Journal of Pharmacology, 1999
- Pro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor γ and Diabetes MellitusBiochemical and Biophysical Research Communications, 1999
- Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1998
- Troglitazone action is independent of adipose tissue.Journal of Clinical Investigation, 1997
- Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.Journal of Clinical Investigation, 1997
- Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDMDiabetes, 1996
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995
- Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM SubjectsDiabetes Care, 1992
- Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDMDiabetes Care, 1991